Enedra Therapeutics
Enedra is harnessing the power of synthetic lethality and advanced computational Systems Biology to create therapeutics that work against the complexity, biological and mutational heterogeneity of cancer.
Focus: Drug discovery platform
Team: Andreas Ballis and Alex Gutteridge
Website: https://enedratx.com/
See other Drug discovery organisations
-
Exogene is a biotechnology company accelerating the discovery of T-cell-receptor (TCR)- based cancer immunotherapies. -
GlamorousAI is AI-first preclinical biotech focusing on the discovery of novel chemistry for challenging targets. -
Human Centric Drug Discovery helps patients with central nervous disorders by making it easier to develop drugs for their diseases. -
Kantify has developed ZeptoNet - a novel AI technology that can perform in silico high-throughput screening...
Be part of SBC Catalyser Programme!
Spaces are limited to a maximum of 10 companies per cohort. Contact Marco to know more or to apply.
Contact MarcoCopyright © 2023 Stevenage Bioscience Catalyst
We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.